Clinical significance of serum neuron-specific enolase in patients with adult T-cell leukemia

American Journal of Hematology

Volumn 71, Issue 2, 2002, Pages 80-84

  Fujiwara, Hiroshi ^a   Arima, Naomichi ^a   Ohtsubo, Hideo ^a   Matsumoto, Tadashi ^b   Kukita, Toshimasa ^a   Kawada, Hideaki ^a   Imaizumi, Rie ^b   Ozaki, Atsuo ^a   Matsushita, Kakushi ^a   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Jiaikai Imamura Hospital   (Japan)

Author keywords

Aggressiveness; ATL; Serum NSE

Indexed keywords

CD30 ANTIGEN; INTERLEUKIN 2 RECEPTOR; NEURON SPECIFIC ENOLASE; THYMIDINE KINASE;

ACUTE LEUKEMIA; ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CHRONIC LEUKEMIA; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HETEROZYGOTE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; LARGE CELL LYMPHOMA; LEUKEMIA CELL; LYMPHOMA; MALE; NONHODGKIN LYMPHOMA; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROGNOSIS; RADIOIMMUNOASSAY; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; T CELL LEUKEMIA; TUMOR CELL;

AGED; ANTIGENS, CD30; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MALE; NEOPLASM PROTEINS; PHOSPHOPYRUVATE HYDRATASE; PROGNOSIS; RADIOIMMUNOASSAY; RECEPTORS, INTERLEUKIN-2; SOLUBILITY; SURVIVAL ANALYSIS; THYMIDINE KINASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0036787291     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10190     Document Type: Article

References (20)

1. Marangos PJ, Zis AP, Clark RL, Goodwin FK. Neuronal, nonneuronal and hybrid forms of enolase in brain: structural, immunological and functional comparisons. Brain Research 1978;150:117-133.
2. Ebert W, Murley TH, Drings P. Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process? Anticancer Res 1996;16:2161-2168.
3. Schmitt UM, Stieber P, Hasholzner U, Hofmann K, Moghadam AF. Methodological and clinical evaluation of two automated enzymatic immunoassay as compared with a radioimmunoassay for neuronspecific enolase. Eur J Clin Chem Clin Biochem 1996;34:679-682.
4. Nemeth J, Galian A, Miko J, Priollet BC, Wassef M, Lavergne A. Neuron-specific enolase and malignant lymphomas. Virchows Arch 1987;412:89-93.
5. Massarelli G, Onida GA, Piras MA, Marras V, Mura A, Tanda F. Neuron-specific enolase (γ enolase, γ-γ dimer) expression in Hodgkin's disease and large cell lymphomas. Anticancer Res 1999;19: 3933-3938.
6. Durkop H, Oberbarnscheidt M, Latza U, Bulfone-Paus S, Hirsch B, Pohl T, Krause H, Hummel M, Stein H. The restricted expression pattern of the Hodgkin's lymphoma-associated cytokine receptor CD30 is regulated by a minimal promoter. J Pathol 2000;192:182-193.
7. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977; 50:481-492.
8. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980;77:7415-7419.
9. Takeshita M, Akamatsu M, Ohshima K, Kobari S, Kikuchi M, Suzumiya J, Uike N, Okamura T. CD30 (Ki-1) expression in adult T-cell leukemia/lymphoma is associated with distinctive immunohistological and clinical characteristics. Histopathology 1995;26:539-546.
10. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. A report from the Lymphoma Study Group (1984-1987). Br J Haematol 1991;79:428-437.
11. Matsushita K, Matsumoto T, Ohtsubo H, Fujiwara H, Imamura N, Hidaka S, Kukita T, Tei C, Matsumoto M, Arima N. Long-term maintenance combination chemotherapy with OPEC/MPEC (vincristine or methotrexate, prednisolone, etoposide and cyclophosphamide) or with daily oral etoposide and prednisolone can improve survival and quality of life in adult T-cell leukemia/lymphoma. Leuk Lymphoma 1999;36: 67-75.
12. Kamihira S, Atogami S, Sohda H, Momita S, Yamada Y, Tomonaga M. Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia. Cancer 1994;73:2753-2758.
13. Sadamori N, Ichiba M, Mine M, Hakariya S, Hayashibara T, Itoyama T, Nakamura H, Tomonaga M, Hayashi K. Clinical significance of serum thymidine kinase in adult T-cell leukemia and acute myeloid leukemia. Br J Hematol 1995;90:100-105.
14. Matsushita K, Arima N, Fujiyoshi T, Daitoku Y, Hidaka S, Ohtsubo H, Fukumori J, Fujiwara H, Matsumoto T, Tanaka H. Interleukin-2-mediated growth of leukemic cells in lymph nodes of patients with adult T-cell leukemia/lymphoma. Leuk Res 1996;20:135-141.
15. Kaplan LE, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
16. Mohammad RM, Hamdan MY, Maki A, Al-Katib A. Induced expression of α-enolase in differentiated diffuse large cell lymphoma. Enzyme Protein 1995;48:37-44.
17. Arima N, Molitor JA, Smith MR, Kim JH, Daitoku Y, Greene WC. Human T-cell leukemia virus type I Tax induces expression of the Rel-related family of κB enhancer-binding proteins: evidence for a pre-translational component of regulation. J Virol 1991;65:6892-6899.
18. Arima N, Matsushita K, Obata H, Ohtsubo H, Fujiwara H, Arimura K, Kukita T, Suruga Y, Wakamatsu S, Hidaka S, Tei C. NF-κB involvement in the activation of primary adult T-cell leukemia cells and its clinical implications. Exp Hematol 1999;27:1168-1175.
19. Moro MA, De Alba J, Cardenas A, De Cristobal J, Leza C, Lizasoain I, Diaz-Guerra MJM, Bosca L, Lorenzo P. Mechanisms of the neuroprotective effect of aspirin after oxygen and glucose derivation in rat forebrain slices. Neuropharmacology 2000;39:1309-1318.
20. Martinez OM, Villanueva J, Abtahi S, Beatty PR, Esquivel CO, Krams S. CD30 expression induces a functional alloreactive human T-lymphocyte subset. Transplantation 1998;65:1240-1247.